Beskrivelse
eerences
Cited: EP-A1- 1161949, WO-A1-2008/007071, WO-A1-2008/007081, WO-A1-2011/054845, WO-A1-2013/029431, US-A- 3520877, LEE YUNG-CHI ET AL: "The protective effect of lactose on lyophilization of CNK-20402.", AAPS PHARMSCITECH 2005 LNKD- PUBMED:16353962, vol.6, no.1, 2005, pages E42-E48, XP002684615, ISSN: 1530-9932, GREGORY J. PACOFSKY ET AL: "Relating the Structure, Activity, and Physical Properties of Ultrashort-Acting Benzodiazepine Receptor Agonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol.12, no.21, 1 November 2002 (2002-11-01), pages 3219-3222, XP055039974, ISSN: 0960-894X, DOI:
10.1016/S0960-894X(02)00513-9, JEFFREY A. STAFFORD ET AL: "Identification and Structure-Activity Studies of Novel Ultrashort-Acting Benzodiazepine Receptor Agonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol.12, no.21, 1 November 2002 (2002-11-01), pages 3215-3218, XP055039851, ISSN: 0960-894X, DOI: 10.1016/S0960-894X(02)00512-7, KARYOPHYLLIS C. TSIAKITZIS ET AL: "Novel Compounds Designed as Antistress Agents", JOURNAL OF MEDICINAL CHEMISTRY, vol.52, no.22, 26 November 2009 (2009-11-26), pages 7315-7318, XP055039992, ISSN: 0022-2623, DOI: 10.1021/jm901169b, BAHETI A ET AL: "Excipients used in lyophilization of small molecules", JOURNAL OF EXCIPIENTS AND FOOD CHEMICALS, INTERNATIONAL PHARMACEUTICAL EXCIPIENTS COUNCIL, AMERICAS, UNITED STATES, vol.1, no.1, 1 January 2010 (2010-01-01) , pages 41-54, XP002676186, ISSN: 2150-2668, PATRICK J. CROWLEY, LUIGI G. MARTINI: "Effects of excipients on the stability of medicinal products", chimica Oggi / CHEMISTRY toda , vol.28, no.51 October 2010 (2010-10-01), pages VII-XIII, XP002684613, Retrieved from the Internet: URL:http://chemistry-today.teknoscienze.co m/pdf/crowley_excipents2010.pdf [retrieved on 2012-10-04], CROWLEY P J: "Excipients as stabilizers", PHARMACEUTICAL SCIENCE AND TECHNOLOGY TODAY 19990601 GB LNKD- DOI:10.1016/S1461-5347(99)00158-3, vol.2, no.
6, 1 June 1999 (1999-06-01), pages 237-243, XP002684614, ISSN: 1461-5347, US-A1- 2006 198896
Enclosed is a translation of the patent claims in Norwegian. Please note that as per the Norwegian Patents Acts, section 66i the patent will receive protection in Norway only as far as there is agreement between the translation and the language of the application/patent granted at the EPO. In matters concerning the validity of the patent, language of the application/patent granted at the EPO will be used as the basis for the decision. The patent documents published by the EPO are available through Espacenet (http://worldwide.espacenet.com) or via the search engine on our website here: https://search.patentstyret.no/
Krav
Fullmektig i Norge:
Fullmektig i EP:
2012.05.22, EP 12168968
BAHETI A ET AL: "Excipients used in lyophilization of small molecules", JOURNAL OF EXCIPIENTS AND FOOD CHEMICALS, INTERNATIONAL PHARMACEUTICAL EXCIPIENTS COUNCIL, AMERICAS, UNITED STATES, vol. 1, no. 1, 1 January 2010 (2010-01-01) , pages 41-54, XP002676186, ISSN: 2150-2668 (B1)
CROWLEY P J: "Excipients as stabilizers", PHARMACEUTICAL SCIENCE AND TECHNOLOGY TODAY 19990601 GB LNKD- DOI:10.1016/S1461-5347(99)00158-3, vol. 2, no. 6, 1 June 1999 (1999-06-01), pages 237-243, XP002684614, ISSN: 1461-5347 (B1)
EP-A1- 1 161 949 (B1)
GREGORY J. PACOFSKY ET AL: "Relating the Structure, Activity, and Physical Properties of Ultrashort-Acting Benzodiazepine Receptor Agonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 12, no. 21, 1 November 2002 (2002-11-01), pages 3219-3222, XP055039974, ISSN: 0960-894X, DOI: 10.1016/S0960-894X(02)00513-9 (B1)
JEFFREY A. STAFFORD ET AL: "Identification and Structure-Activity Studies of Novel Ultrashort-Acting Benzodiazepine Receptor Agonists", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 12, no. 21, 1 November 2002 (2002-11-01), pages 3215-3218, XP055039851, ISSN: 0960-894X, DOI: 10.1016/S0960-894X(02)00512-7 (B1)
KARYOPHYLLIS C. TSIAKITZIS ET AL: "Novel Compounds Designed as Antistress Agents", JOURNAL OF MEDICINAL CHEMISTRY, vol. 52, no. 22, 26 November 2009 (2009-11-26), pages 7315-7318, XP055039992, ISSN: 0022-2623, DOI: 10.1021/jm901169b (B1)
WO-A1-2013/029431 (B1)
PATRICK J. CROWLEY, LUIGI G. MARTINI: "Effects of excipients on the stability of medicinal products", chimica Oggi / CHEMISTRY toda , vol. 28, no. 5 1 October 2010 (2010-10-01), pages VII-XIII, XP002684613, Retrieved from the Internet: URL:http://chemistry-today.teknoscienze.co m/pdf/crowley_excipents2010.pdf [retrieved on 2012-10-04] (B1)
US-A- 3 520 877 (B1)
US-A1- 2006 198 896 (B1)
WO-A1-2008/007071 (B1)
WO-A1-2008/007081 (B1)
WO-A1-2011/054845 (B1)
LEE YUNG-CHI ET AL: "The protective effect of lactose on lyophilization of CNK-20402.", AAPS PHARMSCITECH 2005 LNKD- PUBMED:16353962, vol. 6, no. 1, 2005, pages E42-E48, XP002684615, ISSN: 1530-9932 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Batch Varsel om betaling av første årsavgift (3319)
|
Utgående
EP Registreringsbrev (3210)
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 12. avg. år (EP) | 2024.05.21 | 5010 | PAVIS PAYMENTS GMBH | Betalt og godkjent |
Årsavgift 11. avg. år (EP) | 2023.05.19 | 3500 | PAVIS PAYMENTS GMBH | Betalt og godkjent |
Årsavgift 10. avg. år (EP) | 2022.05.20 | 3200 | PAVIS PAYMENTS GMBH | Betalt og godkjent |
Årsavgift 9. avg. år (EP) | 2021.05.20 | 2850 | PAVIS PAYMENTS GMBH | Betalt og godkjent |
Årsavgift 8. avg. år (EP) | 2020.05.19 | 2550 | 1/PAVIS GMBH | Betalt og godkjent |
Årsavgift 7. avg. år (EP) | 2019.05.22 | 2200 | 1/PAVIS GMBH | Betalt og godkjent |
Årsavgift 6. avg. år (EP) | 2018.05.22 | 2000 | 1/PAVIS GMBH | Betalt og godkjent |
31720807 expand_more expand_less | 2018.01.02 | 5500 | Nordic Patent Service A/S | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|